Julie joined PrimeVigilance in 2024 to support cross functional process design and redesign in order to drive efficiency of our service delivery and create a culture of client focus and operational excellence.

With 20+ years of Pharmacovigilance (PV) experience across the Pharma and CRO industry, Julie has been responsible for leading strategic and operational level planning/optimization for Individual Case Safety Report (ICSR) management and regulatory reporting, ensuring quality and compliant safety data in accordance with global regulatory requirements working across both the clinical development and post-approval environments.

Prior to joining PrimeVigilance, Julie held leadership positions at Syneos Health and PPD. She is an accomplished team leader who provides dynamic, strategic, and operational management and her experience in overseeing initiatives to achieve continuous improvement has proven key to meeting corporate business goals and objectives.

Julie holds a Bachelor of Science degree in Chemistry and Biomedical Sciences from DeMontfort University, UK as well as a Fellowship in Clinical Chemistry from the Institute of Medical Laboratory Science.